What's It Worth? | GenomeWeb

What's It Worth?

Open Access News links to two articles that take different sides on the question of whether the open access movement is anti-publishing. At Scholarly Kitchen, Kent Anderson says it is. "The value proposition is that content is so worthless that you have to pay to have it published, and you can't charge for it even then," he writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.